Laboratorios Richmond Colombia

Laboratorios Richmond Colombia is a pharmaceutical company and a subsidiary of the Argentine group Laboratorios Richmond SACIF. Established in 2016 following the acquisition of Laboratorios Expofarma, the company operates a 2,183 square meter GMP-certified manufacturing facility in Bogota specializing in solid oral dosage forms. Its product portfolio is focused on high-complexity therapeutic areas, including HIV/AIDS, oncology, oncohematology, and neuropsychiatry. The company provides access to essential medicines through local production and strategic technology transfers from its parent organization. Laboratorios Richmond Colombia is recognized for its commitment to innovation and sustainability in the Latin American healthcare market, serving patients across the Andean region.